Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab-680LT Imaging in IBD
NCT06117423Phase 2Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab-680LT in Crohn's disease, ulcerative colitis (UC), sponsored by University Medical Center Groningen. Started Mar 2024; status: recruiting.
02
Drugs
adalimumab-680LT
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06117423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06117423.